83 related articles for article (PubMed ID: 36207440)
1. Histone mimicry by SARS-CoV-2.
York A
Nat Rev Microbiol; 2022 Dec; 20(12):703. PubMed ID: 36207440
[TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry between SARS-CoV-2 and human proteins.
Adiguzel Y
Autoimmun Rev; 2021 Apr; 20(4):102791. PubMed ID: 33610750
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity.
Burgio S; Conway de Macario E; Macario AJ; Cappello F
Cell Stress Chaperones; 2021 Jul; 26(4):611-616. PubMed ID: 33977496
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons.
Lucchese G; Flöel A
Autoimmun Rev; 2020 Jul; 19(7):102556. PubMed ID: 32361194
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2 Interactome 3D: A Web interface for 3D visualization and analysis of SARS-CoV-2-human mimicry and interactions.
Ovek D; Taweel A; Abali Z; Tezsezen E; Koroglu YE; Tsai CJ; Nussinov R; Keskin O; Gursoy A
Bioinformatics; 2022 Feb; 38(5):1455-1457. PubMed ID: 34864889
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 and human retroelements: a case for molecular mimicry?
Koch BF
BMC Genom Data; 2022 Apr; 23(1):27. PubMed ID: 35395708
[TBL] [Abstract][Full Text] [Related]
8. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins.
Nunez-Castilla J; Stebliankin V; Baral P; Balbin CA; Sobhan M; Cickovski T; Mondal AM; Narasimhan G; Chapagain P; Mathee K; Siltberg-Liberles J
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891400
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 ORF8 does not function in the nucleus as a histone mimic.
Liu P; Hu J; Wang L
Protein Cell; 2024 Feb; 15(2):79-82. PubMed ID: 37450559
[No Abstract] [Full Text] [Related]
10. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
Vojdani A; Vojdani E; Kharrazian D
Front Immunol; 2020; 11():617089. PubMed ID: 33584709
[TBL] [Abstract][Full Text] [Related]
11. What is the impact of circulating histones in COVID-19: a systematic review.
Ligi D; Giglio RV; Henry BM; Lippi G; Ciaccio M; Plebani M; Mannello F
Clin Chem Lab Med; 2022 Sep; 60(10):1506-1517. PubMed ID: 35852070
[TBL] [Abstract][Full Text] [Related]
12. Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?
Angileri F; Légaré S; Marino Gammazza A; Conway de Macario E; Macario AJL; Cappello F
Br J Haematol; 2020 Jul; 190(2):e92-e93. PubMed ID: 32453861
[No Abstract] [Full Text] [Related]
13. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.
Obando-Pereda G
J Med Virol; 2021 Sep; 93(9):5350-5357. PubMed ID: 33913542
[TBL] [Abstract][Full Text] [Related]
14. How signalling games explain mimicry at many levels: from viral epidemiology to human sociology.
Casey W; Massey SE; Mishra B
J R Soc Interface; 2021 Feb; 18(175):20200689. PubMed ID: 33622145
[TBL] [Abstract][Full Text] [Related]
15. Molecular mimicry may explain multi-organ damage in COVID-19.
Angileri F; Legare S; Marino Gammazza A; Conway de Macario E; Jl Macario A; Cappello F
Autoimmun Rev; 2020 Aug; 19(8):102591. PubMed ID: 32535095
[No Abstract] [Full Text] [Related]
16. Molecular mimicry between SARS-CoV-2 and the female reproductive system.
Dotan A; Kanduc D; Muller S; Makatsariya A; Shoenfeld Y
Am J Reprod Immunol; 2021 Dec; 86(6):e13494. PubMed ID: 34407240
[TBL] [Abstract][Full Text] [Related]
17. CRESSP: a comprehensive pipeline for prediction of immunopathogenic SARS-CoV-2 epitopes using structural properties of proteins.
An H; Eun M; Yi J; Park J
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35226074
[TBL] [Abstract][Full Text] [Related]
18. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.
Kanduc D; Shoenfeld Y
Immunol Res; 2020 Oct; 68(5):310-313. PubMed ID: 32946016
[No Abstract] [Full Text] [Related]
19. Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells.
Hong W; Yang J; Zou J; Bi Z; He C; Lei H; He X; Li X; Alu A; Ren W; Wang Z; Jiang X; Zhong K; Jia G; Yang Y; Yu W; Huang Q; Yang M; Zhou Y; Zhao Y; Kuang D; Wang J; Wang H; Chen S; Luo M; Zhang Z; Lu T; Chen L; Que H; He Z; Sun Q; Wang W; Shen G; Lu G; Zhao Z; Yang L; Yang J; Wang Z; Li J; Song X; Dai L; Chen C; Geng J; Gou M; Chen L; Dong H; Peng Y; Huang C; Qian Z; Cheng W; Fan C; Wei Y; Su Z; Tong A; Lu S; Peng X; Wei X
Cell Mol Immunol; 2022 May; 19(5):577-587. PubMed ID: 35273357
[TBL] [Abstract][Full Text] [Related]
20. Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors.
Petrenko VA; Gillespie JW; De Plano LM; Shokhen MA
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
